LIFEPharma KEZAD platform unveils AED 700 million investment to expand vaccines, oncology and injectables, strengthening UAE’s healthcare manufacturing ecosystem.
ABU DHABI: LIFEPharma KEZAD platform marks a major milestone in the UAE’s push to strengthen local pharmaceutical manufacturing, with a proposed AED 700 million investment announced at Make it in the Emirates 2026. The initiative follows a strategic agreement between LIFEPharma and AD Ports to establish an advanced production base in Khalifa Economic Zones Abu Dhabi.
The LIFEPharma KEZAD platform will focus on three key segments critical to global healthcare demand. These include an AED 300 million facility for vaccine production, supporting both paediatric and adult immunisation needs. In addition, an AED 200 million oncology manufacturing unit will focus on cancer treatments, alongside another AED 200 million investment in advanced injectables such as biologics and peptides.
This development aligns with the UAE’s broader industrial diversification strategy and aims to reduce reliance on imported medicines. By expanding domestic capabilities, the project is expected to strengthen healthcare resilience while supporting the national “Make in the Emirates” vision.
The LIFEPharma KEZAD platform is projected to contribute around AED 2 billion to the national GDP over time and create more than 1,000 skilled jobs, including opportunities for Emirati talent. The partnership also includes infrastructure and regulatory support, enabling efficient development and long-term scalability.
Leaders highlighted the importance of building local manufacturing capacity for essential medicines, particularly for conditions that significantly impact regional populations. The initiative also reflects growing collaboration between healthcare providers, financial institutions and industrial partners to drive innovation.
As the UAE continues to position pharmaceuticals as a priority sector, this project reinforces its ambition to become a global hub for advanced medical production, combining investment, infrastructure and strategic vision.
